Foresite Capital Management IV’s Relay Therapeutics RLAY Stock Holding History

Foresite Capital Management IV’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.95M	Hold	1,000,000	–	–	4.2%	5
2025 Q4	$8.46M	Hold	1,000,000	–	–	3.68%	5
2025 Q3	$5.22M	Hold	1,000,000	–	–	2.86%	6
2025 Q2	$3.46M	Hold	1,000,000	–	–	2.79%	6
2025 Q1	$2.62M	Hold	1,000,000	–	–	2.36%	5
2024 Q4	$4.12M	Hold	1,000,000	–	–	3.79%	4
2024 Q3	$7.08M	Buy	+1,000,000	New	+$7.47M	4.63%	5
2021 Q3	–	Sell	-556,380	Closed	-$20.4M	–	14
2021 Q2	$20.4M	Sell	556,380 -1,583,000	-74%	-$52.2M	2.75%	8
2021 Q1	$74M	Hold	2,139,380	–	–	8.86%	5
2020 Q4	$88.9M	Hold	2,139,380	–	–	9.66%	3
2020 Q3	$91.1M	Buy	+2,139,380	New	+$81.6M	20.55%	1

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return